Detailed information for compound 26802

Basic information

Technical information
  • TDR Targets ID: 26802
  • Name: 6-fluoro-4-oxo-1H-quinoline-2-carboxylic acid
  • MW: 207.158 | Formula: C10H6FNO3
  • H donors: 2 H acceptors: 4 LogP: 1.79 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc2c(c1)c(O)cc(n2)C(=O)O
  • InChi: 1S/C10H6FNO3/c11-5-1-2-7-6(3-5)9(13)4-8(12-7)10(14)15/h1-4H,(H,12,13)(H,14,15)
  • InChiKey: RHDREWQIVYIOGH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 6-fluoro-4-keto-1H-quinoline-2-carboxylic acid
  • A4135/0176339
  • ZERO/004850

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis inhibitor of apoptosis protein 0.0164 0.427 0.427
Echinococcus multilocularis tissue type plasminogen activator 0.0036 0.0184 0.0184
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0343 1 1
Loa Loa (eye worm) hypothetical protein 0.0164 0.427 0.4163
Schistosoma mansoni hypothetical protein 0.0036 0.0184 0.0184
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 3 0.0033 0.0105 0.0105
Treponema pallidum ATP-dependent RNA helicase 0.0343 1 0.5
Echinococcus granulosus nmda type glutamate receptor 0.0033 0.0105 0.0105
Echinococcus multilocularis baculoviral IAP repeat containing protein 0.0164 0.427 0.427
Mycobacterium tuberculosis Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) 0.0343 1 0.5
Plasmodium vivax RNA helicase-1, putative 0.0343 1 1
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0343 1 0.5
Schistosoma mansoni inhibitor of apoptosis (iap) domain family member 0.0164 0.427 0.427
Leishmania major eukaryotic initiation factor 4a, putative 0.0343 1 1
Entamoeba histolytica DEAD/DEAH box helicase, putative 0.0343 1 0.5
Leishmania major eukaryotic initiation factor 4a, putative 0.0343 1 1
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0343 1 1
Brugia malayi Inhibitor of Apoptosis domain containing protein 0.0164 0.427 0.4163
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0343 1 0.5
Schistosoma mansoni hypothetical protein 0.0164 0.427 0.427
Toxoplasma gondii eukaryotic initiation factor-4A, putative 0.0343 1 1
Onchocerca volvulus Eukaryotic initiation factor 4A homolog 0.0343 1 1
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0343 1 0.5
Echinococcus granulosus inhibitor of apoptosis protein 0.0164 0.427 0.427
Loa Loa (eye worm) hypothetical protein 0.0164 0.427 0.4163
Onchocerca volvulus Deterin homolog 0.0164 0.427 0.4163
Echinococcus granulosus eukaryotic initiation factor 4A III 0.0343 1 1
Onchocerca volvulus 0.0164 0.427 0.4163
Echinococcus multilocularis nmda type glutamate receptor 0.0033 0.0105 0.0105
Schistosoma mansoni inhibitor of apoptosis protein 0.0164 0.427 0.427
Echinococcus granulosus eukaryotic initiation factor 4A 0.0343 1 1
Trypanosoma brucei Eukaryotic initiation factor 4A-1 0.0343 1 0.5
Echinococcus granulosus tissue type plasminogen activator 0.0036 0.0184 0.0184
Echinococcus multilocularis eukaryotic initiation factor 4A III 0.0343 1 1
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0343 1 1
Loa Loa (eye worm) hypothetical protein 0.0343 1 1
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0343 1 1
Echinococcus granulosus baculoviral IAP repeat containing protein 0.0164 0.427 0.427
Echinococcus multilocularis eukaryotic initiation factor 4A 0.0343 1 1
Giardia lamblia Translation initiation factor eIF-4A, putative 0.0343 1 0.5
Plasmodium falciparum eukaryotic initiation factor 4A 0.0343 1 1
Brugia malayi Inhibitor of Apoptosis domain containing protein 0.0164 0.427 0.4163

Activities

Activity type Activity value Assay description Source Reference
Kb (binding) = 48 uM Apparent dissociation constant of [3H]-AMPA from quisqualate receptor of rat cortical slices ChEMBL. 1826744
Kb (binding) = 48 uM Apparent dissociation constant of [3H]-AMPA from quisqualate receptor of rat cortical slices ChEMBL. 1826744
Kb (binding) = 55 uM Apparent dissociation constant of [3H]-kainate from Ionotropic glutamate receptor ionotropic kainate was determined in rat cortical slice preparation ChEMBL. 1826744
Kb (binding) = 55 uM Apparent dissociation constant of [3H]-kainate from Ionotropic glutamate receptor ionotropic kainate was determined in rat cortical slice preparation ChEMBL. 1826744
Kb (binding) = 93 uM Apparent dissociation constant of [3H]-glycine from N-methyl-D-aspartate glutamate receptor in rat cortical slice preparation ChEMBL. 1826744
Kb (binding) = 93 uM Apparent dissociation constant of [3H]-glycine from N-methyl-D-aspartate glutamate receptor in rat cortical slice preparation ChEMBL. 1826744

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.